Our hunch is that Jeff McLaren's (at left) reported recent selling of $469K in HealthStream stock was to help advance his new startup, recently reported by VNC: Medaxion, which aims to help anesthesiologists capture charges via the iPhone platform. The City Paper reports today McLaren's sale, as part of the paper's review of public-companies' insiders' sales and purchases in 2009. McLaren is a co-founder and board member at NASDAQ-listed HSTM.
Monday, December 28, 2009
McLaren draws on HealthStream stake
Our hunch is that Jeff McLaren's (at left) reported recent selling of $469K in HealthStream stock was to help advance his new startup, recently reported by VNC: Medaxion, which aims to help anesthesiologists capture charges via the iPhone platform. The City Paper reports today McLaren's sale, as part of the paper's review of public-companies' insiders' sales and purchases in 2009. McLaren is a co-founder and board member at NASDAQ-listed HSTM.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment